Analyst Reco. Quest Diagnostics Incorporated

Equities

DGX

US74834L1008

Real-time Estimate Cboe BZX Other stock markets 12:25:15 2024-04-25 pm EDT			5-day change	1st Jan Change
135.3 ^USD	-1.64%		+7.52%	-1.81%

12:59pm	Labcorp beats quarterly estimates on strong testing demand	RE
Apr. 24	Jefferies Adjusts Price Target on Quest Diagnostics to $160 From $155	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Jefferies Adjusts Price Target on Quest Diagnostics to $160 From $155	Apr. 24	MT
UBS Adjusts Price Target on Quest Diagnostics to $146 From $139, Maintains Neutral Rating	Apr. 24	MT
Barclays Raises Quest Diagnostics' Price Target to $144 From $138	Apr. 24	MT
Deutsche Bank Adjusts Quest Diagnostics Price Target to $136 From $125, Maintains Hold Rating	Apr. 24	MT
Mizuho Adjusts Quest Diagnostics' Price Target to $155 From $150	Apr. 24	MT
Citigroup Adjusts Quest Diagnostics Price Target to $145 From $135	Apr. 24	MT
Leerink Partners Adjusts Quest Diagnostics Price Target to $141 From $135	Apr. 24	MT
Truist Raises Price Target on Quest Diagnostics to $150 From $145, Cites 'Strong Start' to 2024, Keeps Hold Rating	Apr. 24	MT
Evercore ISI Raises Quest Diagnostics Price Target to $145 from $140	Apr. 23	MT
Leerink Partners Starts Quest Diagnostics With Market Perform Rating, $135 Price Target	Feb. 26	MT
ANALYST RECOMMENDATIONS : Airbnb, Conagra Brands, Berkshire Hathaway, Meta Platforms, Unilever....	Feb. 21
Jefferies Upgrades Quest Diagnostics to Buy From Hold, Adjusts Price Target to $155 From $140	Feb. 07	MT
Fed officials fail to convince investors, who are focused on earnings	Feb. 07
ANALYST RECOMMENDATIONS : Caterpillar, Eli Lilly, Intel, Meta, T-Mobile...	Feb. 07
Deutsche Bank Adjusts Quest Diagnostics Price Target to $125 From $140, Maintains Hold Rating	Feb. 02	MT
ANALYST RECOMMENDATIONS : Burberry Group, Blackrock, JPMorgan Chase, Qualcomm, Sage...	Jan. 15
Analyst recommendations: Blackstone, Citigroup, Icon, Amazon, Broadcom...	Jan. 03
Truist Raises Quest Diagnostics' Price Target to $150 From $145, Keeps Hold Rating	Dec. 20	MT
BofA Securities Upgrades Quest Diagnostics to Buy From Neutral, Adjusts Price Target to $160 From $140	Dec. 12	MT
Citigroup Adjusts Price Target on Quest Diagnostics to $145 From $130, Keeps Neutral Rating	Dec. 11	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Quest Diagnostics Incorporated

Equities

DGX

US74834L1008

Analyst Reco.

Filters